and who does this money losing company have a market cap of $30 Billion. Perhaps it should be $3 Billion.
and it starts to decline from there and there are side effects. After the treatment stops the patient goes back to zero but the side effects such as liver enzymes start to improve.
all prototype manufacturing. Even my dentist uses 3D printing instead of crowns.
and only JNJ has prepared for it as it knows its Zytiga drug comes off patent this year.
ahead of this $30..59 B bubble mkt cap collapse. They don't even own 1% of the stock and are afraid to hold it overnight. They actually only own 0.49 % of the stock that in many cases they got for a penny a share.
and Zytiga from JNJ is preferred by insurers as it is 1/3 less costly, but the generic version will even much less. JNJ is also completing phase 3 on the improved version of Xtandi, known as ARN509.
if it survives.
Every place has wings , TV and beer. P/E is triple what it should be- similar to 1929.
It is only a matter of time with GPRO mkt cap only around $1b. Even declining user growth TWTR has a mkt cap over $25b.
in 3D printing.
regardless of this short term blip.